Large Employer Co-Op Using PBMs In Drug Coverage Initiative, For Now
Health Transformation Alliance partners with CVS and OptumRx on project to lower drug spending in employer-sponsored insurance. Pilot effort expected to involve 20 corporations, save $600m over three years.
You may also be interested in...
Health Transformation Alliance is more interested in how a drug might reduce other medical costs than in pricing alone, CEO Andrews says.
Numerous value frameworks launched over the past few years have encouraged acceptance of cost effectiveness assessments in the US and ICER's influence in the field is growing. Employers may be the next group to promote the concept.
While troubled Valeant was divesting iNova to private equity investors, Novartis announced a pair of oncology-focused deals, out-licensing a brain cancer drug to Midatech and partnering with IBM Watson Health to optimize breast cancer treatment.